FDA tells HRS (Heart Rhythm Society): clinical benefits of ICDs (implantable cardioverter defibrillators) "overlooked"
This article was originally published in Clinica
Executive Summary
The US FDA is developing a "functional indications policy" that will help alleviate some of the confusion that surrounds what patient population claims can be made about implantable cardioverter defibrillators.